Achim Krüger Selected Research

Achim Krüger Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 08/2002
31	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2002
9	Breast Neoplasms (Breast Cancer) 04/2020 - 08/2002
7	Adenocarcinoma 04/2021 - 06/2012
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2015
6	T-Cell Lymphoma (Lymphoma, T Cell) 01/2014 - 10/2002
4	Inflammation (Inflammations) 10/2021 - 08/2002
4	Cachexia 10/2021 - 11/2010
4	Carcinogenesis 01/2021 - 01/2012
4	Lymphoma (Lymphomas) 01/2021 - 03/2008
3	Carcinoma (Carcinomatosis) 01/2014 - 01/2006
3	Fibrosarcoma 01/2014 - 10/2005
3	Ovarian Neoplasms (Ovarian Cancer) 06/2006 - 09/2002
2	Pain (Aches) 08/2019 - 01/2017
2	Chronic Pancreatitis 01/2018 - 11/2016
2	Hematologic Neoplasms (Hematological Malignancy) 12/2015 - 10/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 11/2004
2	Hypoxia (Hypoxemia) 01/2012 - 02/2011
1	Body Weight (Weight, Body) 10/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Metaplasia 01/2021
1	Jaundice (Icterus) 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 10/2014

Drug/Important Bio-Agent (IBA)

14	Tissue Inhibitor of Metalloproteinase-1IBA 01/2021 - 11/2004
12	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2003
10	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2003
10	Matrix Metalloproteinases (MMPs)IBA 11/2016 - 10/2002
9	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2012 - 08/2002
6	Matrix Metalloproteinase InhibitorsIBA 01/2018 - 10/2002
6	Serine Proteases (Serine Protease)IBA 06/2011 - 01/2003
5	Biological ProductsIBA 01/2019 - 08/2002
5	GelatinasesIBA 01/2014 - 10/2002
4	Metalloproteases (Metalloproteinases)IBA 01/2022 - 01/2012
4	Tissue Inhibitor of MetalloproteinasesIBA 11/2021 - 01/2015
4	Monoclonal AntibodiesIBA 04/2021 - 01/2006
4	CathepsinsIBA 01/2019 - 10/2005
4	Pharmaceutical PreparationsIBA 10/2017 - 05/2005
4	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2014 - 01/2006
4	Messenger RNA (mRNA)IBA 12/2012 - 11/2009
4	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2011 - 09/2007
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2018
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2017 - 10/2016
3	matrigelIBA 08/2012 - 05/2006
3	AntibodiesIBA 06/2012 - 01/2003
3	Cathepsin BIBA 01/2012 - 10/2005
3	Cysteine Proteases (Cysteine Protease)IBA 10/2008 - 10/2005
3	Urokinase Plasminogen Activator ReceptorsIBA 08/2004 - 01/2003
2	LigandsIBA 01/2021 - 12/2015
2	Ferritins (Ferritin)IBA 01/2021 - 01/2018
2	CollagenIBA 04/2020 - 01/2015
2	CytokinesIBA 01/2019 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 11/2016 - 11/2010
2	EnzymesIBA 10/2016 - 11/2009
2	DisintegrinsIBA 02/2015 - 09/2007
2	Small Interfering RNA (siRNA)IBA 01/2015 - 03/2008
2	Estrogen ReceptorsIBA 08/2012 - 12/2011
2	Extracellular Matrix ProteinsIBA 08/2012 - 06/2011
2	Cysteine (L-Cysteine)FDA Link 01/2012 - 10/2005
2	Plasminogen InactivatorsIBA 12/2011 - 08/2002
2	Protein Isoforms (Isoforms)IBA 04/2011 - 03/2008
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2010 - 10/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2010 - 08/2010
2	Cystatin CIBA 10/2008 - 10/2005
2	Plasminogen Activator Inhibitor 1IBA 01/2003 - 08/2002
2	Cyclic PeptidesIBA 01/2003 - 09/2002
1	darapladibIBA 10/2021
1	Phospholipases (Phospholipase)IBA 10/2021
1	ProteomeIBA 01/2021
1	AlbuminsIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	invariant chain (Ii-Key)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2021
1	TransferasesIBA 01/2021
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 08/2019
1	CalciumIBA 01/2019
1	Autophagy-Related Protein 5IBA 01/2019
1	Cholinesterases (Cholinesterase)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2017
1	ChemokinesIBA 01/2017
1	Chemokine CXCL12IBA 01/2017
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2015
1	Octreotide (Sandostatin)FDA LinkGeneric 12/2015
1	Proteasome InhibitorsIBA 12/2015
1	TetraspaninsIBA 05/2015
1	Syndecan-4IBA 02/2015
1	ThrombospondinsIBA 02/2015
1	Collagen Type V (Type V Collagen)IBA 01/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2014
1	Cytostatic AgentsIBA 06/2012
1	Caspase 8 (Caspase-8)IBA 06/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 08/2002
1	Precision Medicine 11/2021
1	Injections 11/2016
1	Aftercare (After-Treatment) 01/2015